NCT01345084 2025-03-28
NICAP
Eurofarma Laboratorios S.A.
Phase 3 Withdrawn
Clinical Trials
12 trialsNCT03673735 2021-05-10
ADHERE
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Withdrawn
NCT03488810 2020-08-17
ARN-509
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Withdrawn
NCT04203511 2020-06-09
INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)
Incyte Corporation
Phase 3 Withdrawn
NCT00006451 2020-01-03
Bone Marrow Transplantation in Treating Patients With Leukemia
Masonic Cancer Center, University of Minnesota
Phase 3 Withdrawn
NCT01796444 2018-04-05
Z0011-China
Shandong Cancer Hospital and Institute
Phase 3 Withdrawn
NCT02054559 2016-02-23
ASPIRE
Asan Medical Center
Phase 3 Withdrawn
NCT00006344 2015-05-19
Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer
Virginia Commonwealth University
Phase 3 Withdrawn
NCT00334867 2013-06-28
Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma
Children's Oncology Group
Phase 3 Withdrawn
NCT00055887 2013-05-10
Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer
Spectrum Pharmaceuticals, Inc
Phase 3 Withdrawn
NCT00258466 2013-04-08
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase 3 Withdrawn
NCT00019409 2012-03-23
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
National Institutes of Health Clinical Center (CC)
Phase 3 Withdrawn